Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and beta1 AR blocker in dilated cardiomyopathy postmyocardial infarction - Ahmet, I; Krawczyk, M; Zhu, W; Woo, A Y; Morrell, C; Poosala, S; Xiao, R P; Lakatta, E G; Talan, M I (J Pharmacol Exp Ther, 2008)